Kintor Pharmaceutical Limited

Kintor Pharmaceutical Limitedverified

9939.HK

Price:

$1.98

Market Cap:

$790.12M

Kintor Pharmaceutical Limited, a clinical-stage biotechnology company, engages in developing and commercializing a pipeline of small molecule and biological therapeutics for androgen-receptor-related disease areas with unmet medical needs in the People's Republic of China and internationally. The company's products pipeline include Proxalutamide, a second generation androgen receptor (AR) antagonist for the treatment of metastatic castration-resistant prostate cancer, AR positive breast cancer, and COVID-19; and Pyrilutamide, an AR antagonist for the androgenetic alopecia (AGA) and acne vulgaris treatment. Its products pipeline also comprise ALK-1 antibody for the treatment of metastatic hep...[Read more]

Industry

Biotechnology

IPO Date

2020-05-22

Stock Exchange

HKSE

Ticker

9939.HK

The ROE as of December 2025 (TTM) for Kintor Pharmaceutical Limited (9939.HK) is 0%

According to Kintor Pharmaceutical Limited’s latest financial reports and current stock price. The company's current ROE is 0%. This represents a change of -100.00% compared to the average of -0.05% of the last 4 quarters.

Kintor Pharmaceutical Limited (9939.HK) Historical ROE (quarterly & annually)

How has 9939.HK ROE performed in the past?

The mean historical ROE of Kintor Pharmaceutical Limited over the last ten years is -268.59%. The current 0% ROE has changed -100.00% with respect to the historical average. Over the past ten years (40 quarters), 9939.HK's ROE was at its highest in in the December 2014 quarter at 0%. The ROE was at its lowest in in the December 2017 quarter at -0.64%.

Quarterly (TTM)
Annual

Average

-268.59%

Median

-58.32%

Minimum

-1272.89%

Maximum

-0.43%

Kintor Pharmaceutical Limited (9939.HK) ROE by Quarter and Year

Discovering the peaks and valleys of Kintor Pharmaceutical Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 145.86%

Maximum Annual ROE = -0.43%

Minimum Annual Increase = -99.97%

Minimum Annual ROE = -1272.89%

Quarterly (TTM)
Annual
YearROEChange
2024-52.81%-77.20%
2023-231.56%262.79%
2022-63.83%25.46%
2021-50.88%50.93%
2020-33.71%-94.64%
2019-629.16%145.86%
2018-0.43%-99.97%
2017-1272.89%295.52%
2016-321.83%1.02%
2015-28.80%-54.97%

Kintor Pharmaceutical Limited (9939.HK) Average ROE

How has 9939.HK ROE performed in the past?

The current ROE of Kintor Pharmaceutical Limited (9939.HK) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-116.07%

5-year avg

-86.56%

10-year avg

-268.59%

Kintor Pharmaceutical Limited (9939.HK) ROE vs. Peers

How is 9939.HK’s ROE compared to its peers?

Kintor Pharmaceutical Limited’s ROE is less than CANbridge Pharmaceuticals Inc. (30.81%), less than Uni-Bio Science Group Limited (25.79%), less than Sirnaomics Ltd. (412.36%), greater than China Biotech Services Holdings Limited (-59.63%), greater than ClouDr Group Limited (-78.61%), less than Wenzhou Kangning Hospital Co., Ltd. (4.18%), less than Hospital Corporation of China Limited (31.63%), greater than Suzhou Basecare Medical Corporation Limited (-21.93%), greater than Transcenta Holding Limited (-37.95%), less than Pak Fah Yeow International Limited (9.88%),

Build a custom stock screener for Kintor Pharmaceutical Limited (9939.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kintor Pharmaceutical Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Kintor Pharmaceutical Limited (9939.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Kintor Pharmaceutical Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Kintor Pharmaceutical Limited's ROE?

How is the ROE calculated for Kintor Pharmaceutical Limited (9939.HK)?

What is the highest ROE for Kintor Pharmaceutical Limited (9939.HK)?

What is the 3-year average ROE for Kintor Pharmaceutical Limited (9939.HK)?

What is the 5-year average ROE for Kintor Pharmaceutical Limited (9939.HK)?

How does the current ROE for Kintor Pharmaceutical Limited (9939.HK) compare to its historical average?